APICES Trademark

Trademark Overview

On Monday, October 7, 2013, a trademark application was filed for APICES with the United States Patent and Trademark Office. The USPTO has given the APICES trademark a serial number of 86084205. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 9, 2016. This trademark is owned by Celgene Corporation. The APICES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others; conducting clinical trials for others on the safety and effectiveness of apremilast; conducting clinical trials for others on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials for others on the safety and effectiveness of a drug directed to Prostate-specific antigen
apices

General Information

Serial Number86084205
Word MarkAPICES
Filing DateMonday, October 7, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 9, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2014

Trademark Statements

Goods and ServicesConducting clinical trials for others; conducting clinical trials for others on the safety and effectiveness of apremilast; conducting clinical trials for others on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials for others on the safety and effectiveness of a drug directed to Prostate-specific antigen

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 12, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, May 9, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 9, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 3 GRANTED
Tuesday, August 11, 2015EXTENSION 3 FILED
Tuesday, August 11, 2015TEAS EXTENSION RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2015EXTENSION 2 GRANTED
Monday, March 9, 2015EXTENSION 2 FILED
Tuesday, April 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 9, 2015TEAS EXTENSION RECEIVED
Wednesday, August 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 11, 2014EXTENSION 1 GRANTED
Monday, August 11, 2014EXTENSION 1 FILED
Monday, August 11, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 3, 2014ASSIGNED TO LIE
Thursday, December 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 24, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 24, 2013NON-FINAL ACTION E-MAILED
Tuesday, December 24, 2013NON-FINAL ACTION WRITTEN
Tuesday, December 24, 2013ASSIGNED TO EXAMINER
Saturday, October 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 10, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

apices others conducting trials clinical effectiveness safety drug prostate specific antigen